Anthony P. Adamis

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

David T. Shima, John Bradley, D. Shima, 2007, The American journal of pathology.

VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.

Susumu Ishida, David T. Shima, Yuichi Kaji, 2004, Investigative ophthalmology & visual science.

VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Emmett T. Cunningham, E. Gragoudas, D. Guyer, 2004 .

PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Lawrence A. Yannuzzi, Joan W. Miller, L. Yannuzzi, 2002, Retina.

Ten years of anti-vascular endothelial growth factor therapy

Napoleone Ferrara, A. Adamis, N. Ferrara, 2016, Nature Reviews Drug Discovery.